ETOX ProjectETOX ProjectETOX ProjectETOX ProjectETOX ProjectETOX ProjectETOX Project
  Home > Project > General Information
ETOX Project Print page ETOX Project Send page

 

General Information

 

Summary & Objectives

 

Background & Concept

 

Potential Impact of Project Results

 

Project Activities

 

ETOX Project line

ETOX Project

ETOX Project

 

 

General Information

 

eTOX general presentation

 

  • IMI JU project

  • Full title: Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities (eTOX)

  • Call topic: Development of expert (QSAR) systems for in silico toxicity prediction

  • Duration: 84 months

  • Start date: 1st January 2010

  • Total budget for the project: 18,710,943 €

  • IMI-JU Funding: 6,910,021 €

  • In-kind contribution from EFPIA partners: 10,080,590 €

  • Participant institutions:

EFPIA partners:

. Novartis Pharma AG (project leader)

. AstraZeneca AB

. Bayer Pharma AG (deputy project leader)

. Boehringer Ingelheim International GmbH

. Esteve

. GlaxoSmithKline Research and Development LTD

. Janssen Pharmaceutica NV

. H. Lundbeck A/S

. Pfizer Limited

. F. HOFFMANN-LA ROCHE AG

. UCB Pharma SA

. Sanofi-Aventis Deutschland GmbH

. Institut de Recherches Internationales Servier

 

ACADEMIA partners:

. Fundació Institut Mar d' Investigacions Mčdiques (project management, coordination

of public partners)

. Fundación Centro Nacional de Investigaciones Oncológicas Carlos III

. European Molecular Biology Laboratory

. Liverpool John Moores University

. Technical University of Denmark

. Universität Wien

. VU University Amsterdam

. Fraunhofer Gesellschaft zur Förderung der angewandten Forschung, Institut für

Toxikologie und experimentelle Medizin

. Erasmus Universitair Medisch Centrum Rotterdam

. University of Leicester

. Universitat Politčcnica de Valencia

 

SME partners:

. Lhasa Limited

. Inte:Ligand GmbH

. Molecular Networks GmbH

. Chemotargets SL

. Lead Molecular Design S.L.

. Synapse Research Management Partners SL